Rafael Diaz

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Low Density Lipoprotein

Acute Heart Failure

Acute Coronary Syndrome

Top Venues

European heart journal. Cardiovascular pharmacotherapy

Circulation. Heart failure

European journal of preventive cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Jelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, Christopher Edwards, Marianna Adamo, Mattia Arrigo, Marianela Barros, Jan Biegus, Ovidiu Chioncel, Alain Cohen-Solal, Albertino Damasceno, Rafael Diaz, Gerasimos S Filippatos, Etienne Gayat, Antoine Kimmoun, Valentine Léopold, Riccardo M Inciardi, Maria Novosadova, Matteo Pagnesi, Peter S Pang, Piotr Ponikowski, Hadiza Saidu, Karen Sliwa, Koji Takagi, Jozine M Ter Maaten, Daniela Tomasoni, Carolyn S P Lam, Alexandre Mebazaa, Beth A Davison
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial. Circulation. Heart failure (2024)
Michael Szarek, Esther Reijnders, Ph Gabriel Steg, J Wouter Jukema, Markus Schwertfeger, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Sergio Fazio, Genevieve Garon, Shaun G Goodman, Robert A Harrington, Harvey D White, Andreas M Zeiher, Christa Cobbaert, Gregory G Schwartz
Comparison of Change in Lipoprotein(a) Mass and Molar Concentrations by Alirocumab and Risk of Subsequent Cardiovascular Events in ODYSSEY OUTCOMES. European journal of preventive cardiology (2024)
Shaun G Goodman, Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Robert A Harrington, Johan Wouter Jukema, Harvey D White, Andreas M Zeiher, Garen Manvelian, Robert Pordy, Yann Poulouin, Wanda Stipek, Genevieve Garon, Gregory G Schwartz, null null
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
François Roubille, Nadia Bouabdallaoui, Simon Kouz, David D Waters, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Jean C Grégoire, Habib Gamra, Ghassan S Kiwan, Colin Berry, José López-Sendón, Wolfgang Koenig, Laurent Delorme, Meyer Elbaz, Pierre Coste, Mylène Provencher, Zohar Bassevitch, Lucie Blondeau, Philippe L L'Allier, Marie-Claude Guertin, Jean Claude Tardif
Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes care (2024)
Jelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, Christopher Edwards, Marianna Adamo, Mattia Arrigo, Marianela Barros, Jan Biegus, Ovidiu Chioncel, Alain Cohen-Solal, Albertino Damasceno, Rafael Diaz, Gerasimos S Filippatos, Etienne Gayat, Antoine Kimmoun, Valentine Léopold, Riccardo M Inciardi, Maria Novosadova, Matteo Pagnesi, Peter S Pang, Piotr Ponikowski, Hadiza Saidu, Karen Sliwa, Koji Takagi, Jozine M Ter Maaten, Daniela Tomasoni, Carolyn S P Lam, Alexandre Mebazaa, Beth A Davison
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial. Circulation. Heart failure 17 (4) (2024)
Shaun G Goodman, Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Robert A Harrington, Johan Wouter Jukema, Harvey D White, Andreas M Zeiher, Garen Manvelian, Robert Pordy, Yann Poulouin, Wanda Stipek, Genevieve Garon, Gregory G Schwartz, null null
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
François Roubille, Nadia Bouabdallaoui, Simon Kouz, David D Waters, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Jean C Grégoire, Habib Gamra, Ghassan S Kiwan, Colin Berry, José López-Sendón, Wolfgang Koenig, Laurent Delorme, Meyer Elbaz, Pierre Coste, Mylène Provencher, Zohar Bassevitch, Lucie Blondeau, Philippe L L'Allier, Marie-Claude Guertin, Jean Claude Tardif
Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes care 47 (3) (2024)
Michael Szarek, Esther Reijnders, Ph Gabriel Steg, J Wouter Jukema, Markus Schwertfeger, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Sergio Fazio, Genevieve Garon, Shaun G Goodman, Robert A Harrington, Harvey D White, Andreas M Zeiher, Christa Cobbaert, Gregory G Schwartz
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES. European journal of preventive cardiology 31 (10) (2024)
Jelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Gad Cotter, Christopher Edwards, Marianna Adamo, Mattia Arrigo, Marianela Barros, Jan Biegus, Ovidiu Chioncel, Alain Cohen-Solal, Albertino Damasceno, Rafael Diaz, Gerasimos S Filippatos, Etienne Gayat, Antoine Kimmoun, Valentine Léopold, Riccardo M Inciardi, Maria Novosadova, Matteo Pagnesi, Peter S Pang, Piotr Ponikowski, Hadiza Saidu, Karen Sliwa, Koji Takagi, Jozine M Ter Maaten, Daniela Tomasoni, Carolyn S P Lam, Alexandre Mebazaa, Beth A Davison
Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial. Circulation. Heart failure 17 (4) (2024)
Shaun G Goodman, Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Robert A Harrington, Johan Wouter Jukema, Harvey D White, Andreas M Zeiher, Garen Manvelian, Robert Pordy, Yann Poulouin, Wanda Stipek, Genevieve Garon, Gregory G Schwartz
Safety Of The Pcsk9 Inhibitor Alirocumab: insights From 47,296 Patient-Years Of Observation. European heart journal. Cardiovascular pharmacotherapy (2024)
Shaun G Goodman, Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Robert A Harrington, Johan Wouter Jukema, Harvey D White, Andreas M Zeiher, Garen Manvelian, Robert Pordy, Yann Poulouin, Wanda Stipek, Genevieve Garon, Gregory G Schwartz, null null
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Michael Szarek, Esther Reijnders, Johan Wouter Jukema, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Sergio Fazio, Genevieve Garon, Shaun G Goodman, Robert A Harrington, L Renee Ruhaak, Markus Schwertfeger, Sotirios Tsimikas, Harvey D White, Phillippe Gabriel Steg, Christa M Cobbaert, Gregory G Schwartz, null null
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of Three Tests. Circulation (2023)
Marianna Adamo, Matteo Pagnesi, Alexandre Mebazaa, Beth Davison, Christopher Edwards, Daniela Tomasoni, Mattia Arrigo, Marianela Barros, Jan Biegus, Jelena Celutkiene, Kamilė Čerlinskaitė-Bajorė, Ovidiu Chioncel, Alain Cohen-Solal, Albertino Damasceno, Rafael Diaz, Gerasimos S Filippatos, Etienne Gayat, Antoine Kimmoun, Carolyn S P Lam, Maria Novosadova, Peter S Pang, Piotr Ponikowski, Hadiza Saidu, Karen Sliwa, Koji Takagi, Jozine M Ter Maaten, Carolyn S P Lam, Gad Cotter, Marco Metra
NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial. European heart journal (2023)
Shaun G Goodman, Phillippe Gabriel Steg, Yann Poulouin, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Genevieve Garon, Robert A Harrington, Johan Wouter Jukema, Garen Manvelian, Wanda Stipek, Michael Szarek, Harvey D White, Gregory G Schwartz, null null
Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Trial. Journal of the American Heart Association (2023)
Ulf Landmesser, Jennifer McGinniss, Ph Gabriel Steg, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Mirza Dilic, Shaun G Goodman, J Wouter Jukema, Megan Loy, Ivan Pećin, Robert Pordy, Steen H Poulsen, Michael Szarek, Harvey D White, Gregory G Schwartz, null null
Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab. European journal of preventive cardiology 29 (14) (2022)
Harvey D White, Gregory G Schwartz, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Chern-En Chiang, Rafael Diaz, Shaun G Goodman, Johan Wouter Jukema, Megan Loy, Neha Pagidipati, Robert Pordy, Arsen D Ristić, Andreas M Zeiher, Daniel M Wojdyla, Phillippe Gabriel Steg, null null
Alirocumab after acute coronary syndrome in patients with a history of heart failure. European heart journal 43 (16) (2022)
Emil Wolsk, Brian Lee Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars Køber, Eldrin F Lewis, Aldo Pietro Maggioni, John Joseph Valentine McMurray, Jeffrey L Probstfield, Matthew C Riddle, Scott D Solomon, Jean Claude Tardif, Marc A Pfeffer
Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes. Journal of the American Heart Association 11 (8) (2022)
John William Eikelboom, Jacqueline Bosch, Stuart J Connolly, Jessica Tyrwitt, Keith A A Fox, Eva Muehlhofer, Christoph Neumann, Christoph Tasto, Shrikant I Bangdiwala, Rafael Diaz, Marco Alings, Gilles R Dagenais, Darryl P Leong, Eva M Lonn, Alvaro Avezum, Leopoldo Soares Piegas, Petr Widimsky, Alexander N Parkhomenko, Deepak L Bhatt, Kelley R H Branch, Jeffrey L Probstfield, Patricio Lopez-Jaramillo, Lars Rydén, Nana Pogosova, Katalin Keltai, Matyas Keltai, Georg Ertl, Stefan Stoerk, Antonio L Dans, Fernando Tomás Lanas Zanetti, Yan Liang, Jun Zhu, Christian Torp-Pedersen, Aldo Pietro Maggioni, Patrick J Commerford, Tomasz J Guzik, Thomas Vanassche, Peter Verhamme, Martin O'Donnell, Andrew M Tonkin, John D Varigos, Dragos Vinereanu, Camillo Felix, Jae-Hyung Kim, Khairul S Ibrahim, Basil S Lewis, Kaj P Metsarinne, Victor Aboyans, Phillippe Gabriel Steg, Masatsugu Hori, Ajay Kakkar, Sonia S Anand, Andre Lamy, Mukul Sharma, Salim Yusuf
Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. European heart journal. Cardiovascular pharmacotherapy 8 (8) (2022)
Emil Hagström, Phillippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Tabassome Simon, Rafael Diaz, Shaun G Goodman, Robert A Harrington, Johan Wouter Jukema, Evangelos N Liberopoulos, Nikolaus Marx, Jennifer McGinniss, Garen Manvelian, Robert Pordy, Michel Scemama, Harvey D White, Andreas M Zeiher, Gregory G Schwartz, null null
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Circulation 146 (9) (2022)
Connie N Hess, Eike Sebastian Debus, Mark R Nehler, Sonia S Anand, Manesh R Patel, Michael Szarek, Warren H Capell, Judith Hsia, Joshua A Beckman, Marianne Brodmann, Rafael Diaz, Peter Habertheuer, Nicholas J Leeper, Richard J Powell, Henrik Sillesen, Eva Muehlhofer, Scott D Berkowitz, Lloyd P Haskell, Rupert M Bauersachs, Marc P Bonaca
Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD. Circulation 144 (23) (2021)
Gregory G Schwartz, Michael Szarek, Vera A Bittner, Deepak L Bhatt, Rafael Diaz, Shaun G Goodman, J Wouter Jukema, Megan Loy, Garen Manvelian, Robert Pordy, Harvey D White, Philippe Gabriel Steg, null null
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment. Diabetes care 44 (5) (2021)